STOCK TITAN

AbbVie to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

AbbVie (NYSE: ABBV) will present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 8, 2021. The event will feature key executives including Michael Severino, Robert A. Michael, and Jeffrey R. Stewart, who will participate virtually at 8:40 a.m. Central time.

A live audio webcast will be available on AbbVie's Investor Relations website, with an archived version to follow later that day.

AbbVie aims to deliver innovative medicines across multiple therapeutic areas, enhancing lives and addressing future medical challenges.

Positive
  • None.
Negative
  • None.

NORTH CHICAGO, Ill., June 2, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Goldman Sachs 42nd Annual Global Healthcare Conference on Tuesday, June 8, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present virtually at 8:40 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie's Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

Cision View original content:http://www.prnewswire.com/news-releases/abbvie-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-301303334.html

SOURCE AbbVie

FAQ

When is AbbVie's presentation at the Goldman Sachs Healthcare Conference?

AbbVie will present on June 8, 2021, at 8:40 a.m. Central time.

Who are the key executives presenting for AbbVie at the conference?

The key executives presenting include Michael Severino, Robert A. Michael, and Jeffrey R. Stewart.

Where can I access the live audio webcast of AbbVie's presentation?

You can access the live audio webcast on AbbVie's Investor Relations website.

Will there be an archived version of AbbVie's conference presentation?

Yes, an archived edition of the session will be available later on the same day.

What is AbbVie’s mission in the healthcare field?

AbbVie aims to discover and deliver innovative medicines that address serious health issues.

ABBVIE INC.

NYSE:ABBV

ABBV Rankings

ABBV Latest News

ABBV Stock Data

293.72B
1.77B
0.1%
73.43%
1.03%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NORTH CHICAGO